Personalized chemo dosing may boost leukemia remission in kids
⭐️ CURE ⭐️
Recruiting now
This trial tests whether using advanced genetic testing (NGS) to measure leftover cancer cells after initial treatment can help doctors tailor chemotherapy for children with standard-risk acute lymphoblastic leukemia. Around 116 children aged 1 to 10 will receive a standard chemo…
Phase: PHASE2 • Sponsor: Hee Young Ju • Aim: ⭐️ CURE ⭐️
Last updated Jul 31, 2026 00:00 UTC